+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prediction of plasma concentrations of mianserin and demethylmianserin at steady state from those after an initial dose of mianserin



Prediction of plasma concentrations of mianserin and demethylmianserin at steady state from those after an initial dose of mianserin



Therapeutic Drug Monitoring 15(2): 118-121



The relationships between the plasma concentrations of mianserin and desmethylmianserin at 18 h after initial dosing and those at steady state were studied in 19 depressed patients receiving 30 mg of mianserin at bedtime. Significant linear relationships were observed for mianserin, desmethylmianserin, and mianserin plus desmethylmianserin. The present study thus suggests that the plasma concentrations of these compounds after an initial dose of mianserin can ben used for the prediction of an optimal dose.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009228182

Download citation: RISBibTeXText

PMID: 8503139


Related references

Prediction of Plasma Concentrations of Mianserin and Desmethylmianserin at Steady State from Those After an Initial Dose of Mianserin. Therapeutic Drug Monitoring 15(2): 118-121, 1993

Steady-state plasma concentrations of mianserin and its major active metabolites, demethylmianserin. Therapeutic Drug Monitoring 15(2): 113-117, 1993

Subjective side effects of mianserin in relation to plasma concentrations of mianserin and demethylmianserin. Therapeutic Drug Monitoring 14(3): 190-193, 1992

Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients. Clinical Pharmacokinetics 12(1): 73-78, 1987

Steady-State Plasma Concentrations of Mianserin and Its Major Active Metabolite, Desmethylmianserin. Therapeutic Drug Monitoring 15(2): 113-117, 1993

Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients. European Journal Of Clinical Pharmacology. 53(5): 347-349,., 1998

Subjective Side Effects of Mianserin in Relation to Plasma Concentrations of Mianserin and Desmethylmianserin. Therapeutic Drug Monitoring 14(3): 190-193, 1992

Is there a therapeutic window for plasma concentration of mianserin plus demethylmianserin. Human Psychopharmacology 6(3): 243-248, 1991

The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients. Journal of Clinical Psychopharmacology 17(6): 467-471, 1997

Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients. Pharmacogenetics 7(5): 369-374, 1997

Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine. Therapeutic Drug Monitoring 20(1): 7, 1998

Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients. Chirality 6(7): 555-563, 1994

Prediction of steady-state concentrations of valproic acid as determined from single plasma concentrations after the first dose. Clinical Pharmacy 2(2): 143-147, 1983

Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data. Clinical Pharmacology & Therapeutics 25(5part1): 605-610, 1979

Prediction of steady-state plasma concentrations and individual dosage regimens of tricyclic antidepressants from a single test dose. Therapeutic Drug Monitoring 4(1): 27-31, 1982